Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $9.58 million. The enterprise value is -$5.01 million.

Market Cap	9.58M
Enterprise Value	-5.01M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

APRE has 11.45 million shares outstanding. The number of shares has increased by 18.67% in one year.

Current Share Class	11.45M
Shares Outstanding	11.45M
Shares Change (YoY)	+18.67%
Shares Change (QoQ)	+20.63%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	14.82%
Float	8.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.54
Forward PS	n/a
PB Ratio	0.55
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.63

Current Ratio	5.63
Quick Ratio	5.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.58% and return on invested capital (ROIC) is -48.96%.

Return on Equity (ROE)	-74.58%
Return on Assets (ROA)	-41.45%
Return on Invested Capital (ROIC)	-48.96%
Return on Capital Employed (ROCE)	-100.49%
Weighted Average Cost of Capital (WACC)	12.91%
Revenue Per Employee	$35,720
Profits Per Employee	-$1.57M
Employee Count	8
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.36% in the last 52 weeks. The beta is 1.57, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	-47.36%
50-Day Moving Average	0.81
200-Day Moving Average	1.17
Relative Strength Index (RSI)	49.23
Average Volume (20 Days)	369,220

Short Selling Information

The latest short interest is 109,910, so 0.96% of the outstanding shares have been sold short.

Short Interest	109,910
Short Previous Month	640,347
Short % of Shares Out	0.96%
Short % of Float	1.25%
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, APRE had revenue of $285,759 and -$12.60 million in losses. Loss per share was -$1.93.

Revenue	285,759
Gross Profit	-6.76M
Operating Income	-13.23M
Pretax Income	-12.60M
Net Income	-12.60M
EBITDA	-13.21M
EBIT	-13.23M
Loss Per Share	-$1.93

Full Income Statement

Balance Sheet

The company has $14.60 million in cash and n/a in debt, giving a net cash position of $14.60 million or $1.27 per share.

Cash & Cash Equivalents	14.60M
Total Debt	n/a
Net Cash	14.60M
Net Cash Per Share	$1.27
Equity (Book Value)	13.17M
Book Value Per Share	1.52
Working Capital	12.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.89M
Capital Expenditures	n/a
Depreciation & Amortization	21,715
Net Borrowing	n/a
Free Cash Flow	-12.89M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4,631.12%
Pretax Margin	-4,409.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.67%
Shareholder Yield	-18.67%
Earnings Yield	-131.46%
FCF Yield	-134.53%

Analyst Forecast

The average price target for APRE is $4.10, which is 389.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.10
Price Target Difference	389.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	156.18%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

APRE has an Altman Z-Score of -28.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.75
Piotroski F-Score	n/a